pf-05212372
Showing 1 - 1 of 1
Phase 1, Single Dose, Safety Trial in Bruxelles (PF-05212372, Placebo)
Completed
- Phase 1
- +4 more
- PF-05212372
- Placebo
-
Bruxelles, BelgiumPfizer Investigational Site
Aug 12, 2011